Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling.

Roberts GP, Larraufie P, Richards P, Kay RG, Galvin SG, Miedzybrodzka EL, Leiter A, Li HJ, Glass LL, Ma MKL, Lam B, Yeo GSH, Scharfmann R, Chiarugi D, Hardwick RH, Reimann F, Gribble FM.

Diabetes. 2019 Feb 7. pii: db180883. doi: 10.2337/db18-0883. [Epub ahead of print]

PMID:
30733330
2.

Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery.

Larraufie P, Roberts GP, McGavigan AK, Kay RG, Li J, Leiter A, Melvin A, Biggs EK, Ravn P, Davy K, Hornigold DC, Yeo GSH, Hardwick RH, Reimann F, Gribble FM.

Cell Rep. 2019 Feb 5;26(6):1399-1408.e6. doi: 10.1016/j.celrep.2019.01.047.

3.

Dual binding motifs underpin the hierarchical association of perilipins1-3 with lipid droplets.

Ajjaji D, Ben M'barek K, Mimmack ML, England C, Herscovitz H, Dong L, Kay RG, Patel S, Saudek V, Small DM, Savage DB, Thiam AR.

Mol Biol Cell. 2019 Mar 1;30(5):703-716. doi: 10.1091/mbc.E18-08-0534. Epub 2019 Jan 16.

PMID:
30649995
4.

Trophoblast organoids as a model for maternal-fetal interactions during human placentation.

Turco MY, Gardner L, Kay RG, Hamilton RS, Prater M, Hollinshead MS, McWhinnie A, Esposito L, Fernando R, Skelton H, Reimann F, Gribble FM, Sharkey A, Marsh SGE, O'Rahilly S, Hemberger M, Burton GJ, Moffett A.

Nature. 2018 Dec;564(7735):263-267. doi: 10.1038/s41586-018-0753-3. Epub 2018 Nov 28.

PMID:
30487605
5.

Improved reference genome of Aedes aegypti informs arbovirus vector control.

Matthews BJ, Dudchenko O, Kingan SB, Koren S, Antoshechkin I, Crawford JE, Glassford WJ, Herre M, Redmond SN, Rose NH, Weedall GD, Wu Y, Batra SS, Brito-Sierra CA, Buckingham SD, Campbell CL, Chan S, Cox E, Evans BR, Fansiri T, Filipović I, Fontaine A, Gloria-Soria A, Hall R, Joardar VS, Jones AK, Kay RGG, Kodali VK, Lee J, Lycett GJ, Mitchell SN, Muehling J, Murphy MR, Omer AD, Partridge FA, Peluso P, Aiden AP, Ramasamy V, Rašić G, Roy S, Saavedra-Rodriguez K, Sharan S, Sharma A, Smith ML, Turner J, Weakley AM, Zhao Z, Akbari OS, Black WC 4th, Cao H, Darby AC, Hill CA, Johnston JS, Murphy TD, Raikhel AS, Sattelle DB, Sharakhov IV, White BJ, Zhao L, Aiden EL, Mann RS, Lambrechts L, Powell JR, Sharakhova MV, Tu Z, Robertson HM, McBride CS, Hastie AR, Korlach J, Neafsey DE, Phillippy AM, Vosshall LB.

Nature. 2018 Nov;563(7732):501-507. doi: 10.1038/s41586-018-0692-z. Epub 2018 Nov 14.

PMID:
30429615
6.

Quantitative mass spectrometry for human melanocortin peptides in vitro and in vivo suggests prominent roles for β-MSH and desacetyl α-MSH in energy homeostasis.

Kirwan P, Kay RG, Brouwers B, Herranz-Pérez V, Jura M, Larraufie P, Jerber J, Pembroke J, Bartels T, White A, Gribble FM, Reimann F, Farooqi IS, O'Rahilly S, Merkle FT.

Mol Metab. 2018 Nov;17:82-97. doi: 10.1016/j.molmet.2018.08.006. Epub 2018 Aug 21.

7.

Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.

Billing LJ, Smith CA, Larraufie P, Goldspink DA, Galvin S, Kay RG, Howe JD, Walker R, Pruna M, Glass L, Pais R, Gribble FM, Reimann F.

Mol Metab. 2018 Oct;16:65-75. doi: 10.1016/j.molmet.2018.07.011. Epub 2018 Jul 30.

8.

Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome.

Church D, Cardoso L, Kay RG, Williams CL, Freudenthal B, Clarke C, Harris J, Moorthy M, Karra E, Gribble FM, Reimann F, Burling K, Williams AJK, Munir A, Jones TH, Führer D, Moeller LC, Cohen M, Khoo B, Halsall D, Semple RK.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3845-3855. doi: 10.1210/jc.2018-00972.

9.

Glu-C, an alternative digestive enzyme for the quantitative LC-MS/MS analysis of an IgG-based antibody biotherapeutic.

Hansen K, Szarka S, Escoffier E, Berthet A, Venet J, Collet-Brose J, Hepburn S, Wright M, Wheller R, Nelson R, Kay RG.

Bioanalysis. 2018 Jul 1;10(13):997-1007. doi: 10.4155/bio-2017-0259. Epub 2018 Jul 4.

PMID:
29972309
10.

Peptidomic analysis of endogenous plasma peptides from patients with pancreatic neuroendocrine tumours.

Kay RG, Challis BG, Casey RT, Roberts GP, Meek CL, Reimann F, Gribble FM.

Rapid Commun Mass Spectrom. 2018 Aug 30;32(16):1414-1424. doi: 10.1002/rcm.8183.

11.

Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.

Roberts GP, Kay RG, Howard J, Hardwick RH, Reimann F, Gribble FM.

Surg Obes Relat Dis. 2018 May;14(5):562-568. doi: 10.1016/j.soard.2018.01.039. Epub 2018 Feb 3.

12.

Single-cell RNA-sequencing reveals a distinct population of proglucagon-expressing cells specific to the mouse upper small intestine.

Glass LL, Calero-Nieto FJ, Jawaid W, Larraufie P, Kay RG, Göttgens B, Reimann F, Gribble FM.

Mol Metab. 2017 Oct;6(10):1296-1303. doi: 10.1016/j.molmet.2017.07.014. Epub 2017 Aug 1.

13.

Liquid chromatography/mass spectrometry based detection and semi-quantitative analysis of INSL5 in human and murine tissues.

Kay RG, Galvin S, Larraufie P, Reimann F, Gribble FM.

Rapid Commun Mass Spectrom. 2017 Dec 15;31(23):1963-1973. doi: 10.1002/rcm.7978.

14.

Development of a UHPLC-MS/MS (SRM) method for the quantitation of endogenous glucagon and dosed GLP-1 from human plasma.

Howard JW, Kay RG, Jones B, Cegla J, Tan T, Bloom S, Creaser CS.

Bioanalysis. 2017 May;9(9):733-751. doi: 10.4155/bio-2017-0021. Epub 2017 May 10.

PMID:
28488894
15.

Comparative Transcriptomics of Malaria Mosquito Testes: Function, Evolution, and Linkage.

Cassone BJ, Kay RG, Daugherty MP, White BJ.

G3 (Bethesda). 2017 Apr 3;7(4):1127-1136. doi: 10.1534/g3.117.040089.

16.

A current perspective of supercharging reagents and peptide bioanalysis.

Kay RG, Howard J, Stensson S.

Bioanalysis. 2016 Feb;8(3):157-61. doi: 10.4155/bio.15.247. Epub 2016 Jan 25. Review. No abstract available.

PMID:
26805961
17.

Validation of an ultrasensitive LC-MS/MS method for PTH 1-34 in porcine plasma to support a solid dose PK study.

Kay RG, Hands JT, Hawthorne G, Constable S, Grosvenor M, Sharman JA.

Bioanalysis. 2015;7(12):1435-45. doi: 10.4155/bio.15.75.

PMID:
26168251
18.

Identification of plasma protease derived metabolites of glucagon and their formation under typical laboratory sample handling conditions.

Howard JW, Kay RG, Tan T, Minnion J, Creaser CS.

Rapid Commun Mass Spectrom. 2015 Jan 30;29(2):171-81. doi: 10.1002/rcm.7090.

19.

Development of a high-throughput UHPLC-MS/MS (SRM) method for the quantitation of endogenous glucagon from human plasma.

Howard JW, Kay RG, Tan T, Minnion J, Ghatei M, Bloom S, Creaser CS.

Bioanalysis. 2014;6(24):3295-309. doi: 10.4155/bio.14.226.

20.

John Edwin Horton 1931–2012.

Kay RG.

N Z Med J. 2014 Mar 28;127(1391):1. No abstract available.

PMID:
24851313
21.

UHPLC for the separation of proteins and peptides.

Howard JW, Kay RG, Pleasance S, Creaser CS.

Bioanalysis. 2012 Dec;4(24):2971-88. doi: 10.4155/bio.12.283. Review.

PMID:
23244286
22.

In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues.

Julien M, Kay RG, Delhanty PJ, Allas S, Granata R, Barton C, Constable S, Ghigo E, van der Lely AJ, Abribat T.

Eur J Pharm Sci. 2012 Nov 20;47(4):625-35. doi: 10.1016/j.ejps.2012.07.014. Epub 2012 Jul 25.

PMID:
22841845
23.

Bioanalysis of biotherapeutic proteins and peptides: immunological or MS approach?

Kay RG, Roberts A.

Bioanalysis. 2012 May;4(8):857-60. doi: 10.4155/bio.12.66. No abstract available.

24.

Application of mass spectrometry-based proteomics techniques for the detection of protein doping in sports.

Kay RG, Creaser CS.

Expert Rev Proteomics. 2010 Apr;7(2):185-8. doi: 10.1586/epr.10.11.

PMID:
20377386
25.

Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins.

Barton C, Kay RG, Gentzer W, Vitzthum F, Pleasance S.

J Proteome Res. 2010 Jan;9(1):333-40. doi: 10.1021/pr900658d.

PMID:
19921931
26.

High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration.

Kay RG, Barton C, Velloso CP, Brown PR, Bartlett C, Blazevich AJ, Godfrey RJ, Goldspink G, Rees R, Ball GR, Cowan DA, Harridge SD, Roberts J, Teale P, Creaser CS.

Rapid Commun Mass Spectrom. 2009 Oct;23(19):3173-82. doi: 10.1002/rcm.4237.

PMID:
19718777
27.

Biomarkers: unrealized potential in sports doping analysis.

Teale P, Barton C, Driver PM, Kay RG.

Bioanalysis. 2009 Sep;1(6):1103-18. doi: 10.4155/bio.09.87. Review.

PMID:
21083078
28.

MRMaid, the web-based tool for designing multiple reaction monitoring (MRM) transitions.

Mead JA, Bianco L, Ottone V, Barton C, Kay RG, Lilley KS, Bond NJ, Bessant C.

Mol Cell Proteomics. 2009 Apr;8(4):696-705. doi: 10.1074/mcp.M800192-MCP200. Epub 2008 Nov 15.

29.
30.

Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients.

Cundy T, Evans MC, Kay RG, Dowman M, Wattie D, Reid IR.

Br J Surg. 1996 Oct;83(10):1468-72.

PMID:
8944476
31.

Treatment of breast cancer in the Auckland region 1976-85.

Mason BH, Holdaway IM, Newman PD, Kay RG, Benjamin C, Harvey VJ.

N Z Med J. 1994 Mar 23;107(974):93-6.

PMID:
8127516
32.
33.

Detection of contralateral breast cancer by mammography in women with previous breast cancer and the impact of endocrine therapy.

Mason BH, Holdaway IM, Benton NM, Benson-Cooper DM, Hadden WE, Kay RG.

N Z Med J. 1993 Feb 10;106(949):23-5.

PMID:
8464582
34.

Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. Auckland Breast Cancer Study Group.

Lethaby AE, Mason BH, Holdaway IM, Kay RG.

N Z Med J. 1992 Dec 9;105(947):485-8. Erratum in: N Z Med J 1993 Apr 28;106(954):166.

PMID:
1461604
35.

Incidence and clinical features of breast cancer in the Auckland region.

Newman PD, Mason BH, Holdaway IM, Kay RG, Arthur JF, Hitchcock GC.

N Z Med J. 1992 Apr 8;105(931):117-20.

PMID:
1313956
36.

Seasonal change in the concentration of progesterone receptor in breast cancer.

Holdaway IM, Mason BH, Marshall RJ, Neave LM, Kay RG.

Cancer Res. 1990 Sep 15;50(18):5883-6.

37.

Does delay in diagnosis of breast cancer affect survival?

Neave LM, Mason BH, Kay RG.

Breast Cancer Res Treat. 1990 Feb;15(2):103-8.

PMID:
2322648
38.

Season of tumour detection influences factors predicting survival of patients with breast cancer.

Mason BH, Holdaway IM, Stewart AW, Neave LM, Kay RG.

Breast Cancer Res Treat. 1990 Jan;15(1):27-37.

PMID:
2328328
39.

Season of initial discovery of tumour as an independent variable predicting survival in breast cancer.

Mason BH, Holdaway IM, Stewart AW, Neave LM, Kay RG.

Br J Cancer. 1990 Jan;61(1):137-41.

40.

Association between season of first detection of breast cancer and disease progression.

Mason BH, Holdaway IM, Skinner SJ, Stewart AW, Kay RG, Neave LM, Anderson J.

Breast Cancer Res Treat. 1987;9(3):227-32.

PMID:
3663959
41.

Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand.

McNee RK, Mason BH, Neave LM, Kay RG.

Breast Cancer Res Treat. 1987;9(2):145-50. Erratum in: Breast Cancer Res Treat 1988 Apr;11(1):79.

PMID:
3620716
42.

Plasma manganese in an adult Auckland population group.

Knight GS, Kay RG.

N Z Med J. 1985 Aug 28;98(785):712-3. No abstract available.

PMID:
3863042
43.

Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status.

Mason BH, Holdaway IM, Mullins PR, Kay RG, Skinner SJ.

Breast Cancer Res Treat. 1985;5(2):171-6. Erratum in: Breast Cancer Res Treat 1986;7(1):51.

PMID:
4016283
44.

Estrogen receptor status, adrenal androgens and 7 alpha-hydroxydehydroepiandrosterone in breast cancer patients.

Skinner SJ, Holdaway IM, Mason BH, Couch RA, Kay RG.

Eur J Cancer Clin Oncol. 1984 Oct;20(10):1227-31.

PMID:
6237915
45.

Steroid hormone receptors in breast tumours presenting during pregnancy or lactation.

Holdaway IM, Mason BH, Kay RG.

J Surg Oncol. 1984 Jan;25(1):38-41.

PMID:
6694391
46.

Progesterone and estrogen receptors as prognostic variables in breast cancer.

Mason BH, Holdaway IM, Mullins PR, Yee LH, Kay RG.

Cancer Res. 1983 Jun;43(6):2985-90.

47.

Levamisole in primary breast cancer. A controlled study in conjunction with l-phenylalanine mustard.

Kay RG, Mason BH, Stephens EJ, Arthur JF, Hitchcock GC, Trindall PL, Rodgers R, Mullins P.

Cancer. 1983 Jun 1;51(11):1992-7.

PMID:
6340820
48.

Zinc and copper in human nutrition.

Kay RG.

J Hum Nutr. 1981 Feb;35(1):25-36. Review. No abstract available.

PMID:
6782156
49.

The relationship of plasma 7 alpha-hydroxy dehydroepiandrosterone to disease stage and adrenal androgens in breast cancer patients.

Skinner SJ, Couch RA, Thambyah S, Dobbs RJ, Jordan SM, Mason B, Kay RG.

Eur J Cancer. 1980 Feb;16(2):223-8. No abstract available.

PMID:
6445272
50.

Blood selenium values in an adult Auckland population group.

Kay RG, Knight GS.

N Z Med J. 1979 Jul 11;90(639):11-3.

PMID:
290885

Supplemental Content

Support Center